Back to Search
Start Over
Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries.
- Source :
-
Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2008 Dec; Vol. 97 (12), pp. 891-8. Date of Electronic Publication: 2008 Sep 05. - Publication Year :
- 2008
-
Abstract
- Background: The major drawback of stent implantation in native human coronary vessels is the occurrence of restenosis. Drug-eluting stents significantly reduce restenosis after percutaneous coronary intervention (PCI), but may be associated with persistent local inflammation involved in the restenosis mechanisms. In this setting coating coronary devices with anti-inflammatory agents represents an intriguing alternative to stent-based local drug delivery. The aim of the present study was to test in a porcine model the safety and efficacy of a novel Genistein-eluting balloon preceding coronary stenting.<br />Design: Female piglets underwent PCI in a randomized fashion with either a Genistein-eluting or a standard balloon angioplasty, followed in all vessels by bare-metal stent implantation. Pigs were sacrificed at different time points to appraise safety (i.e. endothelialization) and efficacy (i.e. anti-inflammatory and anti-proliferative effects): 1, 4, and 6-8 weeks following PCI.<br />Results: Overall analysis was conducted on 14 piglets. Twenty-five bare-metal stents were implanted preceded by angioplasty with a conventional balloon in 13 vessels and by the Genistein-eluted balloon in 12. No untoward effects were reported in either group. Healing and endothelialization appeared universal within 4 weeks. The Genistein-eluted balloon group disclosed a significant reduction, at four weeks from implantation, of the peri-stent inflammatory cells count (mononucleocytes 39 +/- 32 Vs. 96 +/- 29 per square millimetre, P = 0.019). This effect did not clearly translate into a trend towards a reduced neointimal hyperplasia at 6-8 weeks (0.13 +/- 0.11 Vs. 0.14 +/- 0.09, P = 0.835).<br />Conclusion: This study provides the first in vivo demonstration of the anti-inflammatory effects of a Genistein-eluting balloon in PCI, warranting further research including the combination of a Genistein-eluting balloon with standard drug-eluting stent.
- Subjects :
- Angioplasty, Balloon adverse effects
Angioplasty, Balloon, Coronary methods
Animals
Anti-Inflammatory Agents adverse effects
Coronary Restenosis etiology
Coronary Restenosis prevention & control
Disease Models, Animal
Drug-Eluting Stents adverse effects
Endothelium, Vascular drug effects
Endothelium, Vascular pathology
Female
Genistein adverse effects
Hyperplasia etiology
Hyperplasia prevention & control
Inflammation etiology
Inflammation prevention & control
Random Allocation
Swine
Time Factors
Tunica Intima drug effects
Tunica Intima pathology
Angioplasty, Balloon methods
Anti-Inflammatory Agents administration & dosage
Genistein administration & dosage
Stents
Subjects
Details
- Language :
- English
- ISSN :
- 1861-0692
- Volume :
- 97
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Clinical research in cardiology : official journal of the German Cardiac Society
- Publication Type :
- Academic Journal
- Accession number :
- 18777002
- Full Text :
- https://doi.org/10.1007/s00392-008-0705-2